Results 21 to 30 of about 7,703 (180)

Types of testicular tumors in Shahid Beheshti Hospital of Babol, Iran, during 2001‒2021 [PDF]

open access: yesمجله پزشکی دانشگاه علوم پزشکی تبریز
Background. Testicular tumors account for about 1% of all male cancers. Considering that there is no accurate information about the prevalence of testicular tumors in Iran, this study aimed to investigate the types of testicular tumors in the hospitals ...
Sorena Samimi   +2 more
doaj   +1 more source

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma

open access: yesFrontiers in Oncology, 2022
BackgroundRadiological evaluation of postchemotherapy residual masses of metastatic seminoma is characterized by poor diagnostic accuracy. Serum levels of microRNA-371a-3p (M371) involve high specificity and sensitivity for the primary diagnosis of ...
Klaus-Peter Dieckmann   +7 more
doaj   +1 more source

Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis

open access: yesCancer Informatics, 2022
Objective: Testicular germ cell tumors (TGCT) are the most common solid malignancy in adolescent and young men, with a rising incidence over the past 20 years.
Kirill E Medvedev   +5 more
doaj   +1 more source

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

open access: yesBMC Cancer, 2019
Background To validate the utility of the chemokine ligand 12 (CXCL12) as prognostic marker in patients with localized and metastatic germ cell tumors (GCT).
Christian Daniel Fankhauser   +9 more
doaj   +1 more source

Stage I Testicular Non Seminoma [PDF]

open access: yesOnkologie, 2011
disadvantage in basing a follow up schedule on only 2 scans, one at 3 and one at 12 months after orchidectomy [6]. Given the efficacy of treatment of systemic disease, should all patients with stage I non seminoma be managed by surveillance, as has been suggested for stage I seminoma [7]? The treatment burden modeling by Kollmannsberger et al.
openaire   +1 more source

Karakteristik dan Faktor-faktor Prediktif pada Tumor Testis Dewasa di Jakarta

open access: yesIndonesian Journal of Cancer, 2007
Penelitian ini bertujuan untuk mengetahui karakteristik dan faktor-faktor prediktif tumor testis dewasa di Jakarta. Data dikumpulkan dari status khusus di departemen urologi RSCM dan RS kanker Dharmais. Data yang dikumpulkan adalah usia, tumor marker
Tri Endah Suprabawati, Rainy Umbas
doaj   +1 more source

Serum RNA Profiling in the 10-Years Period Prior to Diagnosis of Testicular Germ Cell Tumor

open access: yesFrontiers in Oncology, 2020
Although testicular germ cell tumor (TGCT) overall is highly curable, patients may experience late effects after treatment. An increased understanding of the mechanisms behind the development of TGCT may pave the way for better outcome for patients.
Joshua Burton   +7 more
doaj   +1 more source

Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages

open access: yesMedicina, 2023
Background and Objectives: The impact of pure histological subtypes in testicular non-seminoma germ cell tumors on survival, specifically regarding pure embryonal carcinoma, is not well established.
Cristina Cano Garcia   +19 more
doaj   +1 more source

Analisis Ketahanan Hidup Tumor Testis Sel Germinal di RS Sardjito Periode 2007-2013

open access: yesIndonesian Journal of Cancer, 2016
Objective: To know survival of germ cell testicle tumor at Sardjito hospital who had chemotherapy or radiotherapy and its factor which influenced their survival Method: From year 2007 until 2013, we collected patients with germ cell testicle tumor at ...
Denny Achmad Prayoga, HR Danarto
doaj   +1 more source

Use of Sotrovimab for COVID-19 in a Patient with International Germ Cell Consensus Classification Poor Prognosis Testicular Germ Cell Tumor

open access: yesCase Reports in Oncology, 2023
A 35-year-old man was diagnosed with stage IIIC non-seminoma with paralysis of the lower half of his body due to 8th thoracic spine metastasis. The patient received bleomycin, etoposide, and cisplatin (BEP) therapy.
Hirotaka Nagasaka   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy